Photothermal therapy of copper incorporated nanomaterials for biomedicine

Wang, Rong; Huang, Ziwei; Xiao, Yunxiao; Huang, Tao; Ming, Jie

doi:10.1186/s40824-023-00461-z

Biomaterials Research

Table 1 Applications of CINMs-based PTT in cancer therapy and imaging

From: Photothermal therapy of copper incorporated nanomaterials for biomedicine

Nanomaterial	Therapeutic remarks	Laser parameters	Tumor model	Reference
IPNs	PTT/chemotherapy/PDT	980 nm, 2.0 W·cm⁻², 15 min	4T1 tumor	[14]
Cu₂O@CaCO₃@HA (CCH)	PTT/PDT/CDT/immunotherapy	1064 nm, 0.5 W·cm⁻², 5 min	CT26.WT tumor	[15]
LDH-CuS	PTT/CDT/PDT/PAI/lysosome-targeting	808 nm, 1.5 W·cm⁻², 5 min	4T1 tumor	[39]
Gox@CuS	PTT/CDT/PDT/starvation therapy	808 nm, 5.0 W·cm⁻², 10 min	B16F10 tumor	[40]
TRF-mCuGd	PTT/CDT/MRI	808 nm, 0.8 W·cm⁻², 10 min	MDA-MB-231 and MCF-7/DDP tumors	[27]
Cu₃BiS₃ nanorods	PTT/radiotherapy/PAI/CT	1064 nm, 1.0 W·cm⁻², 6 min	4T1 tumor	[41]
Cu₂MoS₄ (CMS)/Au	PTT/PDT/immunotherapy/CT/PAI	808 nm, 0.5 W·cm⁻², 5 min	U14 tumor	[19]
BCGCR	PTT/CDT/MRI/NIRF	980 nm, 0.8 W·cm⁻², 10 min	U87MG tumor	[42]
HMSNs@PDA-Cu	PTT/CDT	808 nm, 0.6 W·cm⁻², 3 min	MCF-7 tumor	[43]
ICG/Cu-LDH@BSA-DOX	PTT/PDT/chemotherapy	808 nm, 0.3 W·cm⁻², 2 min	B16F0 tumor	[44]
HMON@CuS/Gd	PTT/PDT/MRI/fluorescence	808 nm, 0.8 W·cm⁻², 8 min	HGC-27 tumor	[45]
CuS NPs-PEG-Mal	PTT/immunotherapy	808 nm, 0.45 W·cm⁻², 5 min	4T1 tumor	[46]
FA-CD@PP-CpG	PTT/PDT/chemotherapy/immunotherapy	650 nm, 4.5 mW·cm⁻², 5 min for PDT; 808 nm, 0.987 W·cm⁻², 5 min for PTT	4T1 tumor	[47]
CuS@OVA-PLGA-NPs	PTT/immunotherapy	980 nm, 1.0 W·cm⁻², 10 min	4T1 tumor	[48]
CuS-SF@CMV	PTT/immunotherapy/chemotherapy	808 nm, 0.6 W·cm⁻², 5 min	H22 tumor	[49]
Cu₂MnS₂ NPs	PTT/MRI/MSOT	1064 nm, 0.6 W·cm⁻², 10 min	S180 tumor	[50]
Cu₂ZnSnS₄ (CZTS)@BSA	PTT/MRI/PAI	808 nm, 1.0 W·cm⁻², 5 min	H22 tumor	[51]
Cu_2-xSe-Au Janus NPs	PTT/CDT/photocatalytic therapy/CT/PAI	808 nm, 0.36 W·cm⁻², 10 min	4T1 tumor	[52]
C-m-ABs	PTT/PDT/CDT/chemotherapy/MRI/PA/NIRF	808 nm, 1.4 W·cm⁻², 8 min	MGC-803 tumor	[53]
Au@Cu₂O	PTT/PAI	808 nm, 1.0 W·cm⁻², 5 min	HCT tumor	[22]
Core–satellite nanoconstructs (CSNC)	PTT/PDT/PET/fluorescence/Cerenkov luminescence/Cerenkov radiation energy transfer	980 nm, 4.0 W·cm⁻², 10 min for PTT; 660 nm, 0.05 W·cm⁻², 20 min for PDT	4T1 tumor	[54]
BPMN-CuS/DOX	PTT/chemotherapy/CDT	808 nm, 1.0 W·cm⁻², 3 min	B16F10 tumor	[55]
PZTC/SS/HA	PTT/CDT	1064 nm, 1.0 W·cm⁻², 10 min	HCT-116 tumor	[56]
Cu-BTC@PDA	PTT/CDT	808 nm, 1.0 W·cm⁻², 10 min	B16F10 tumor	[57]
CAL@PG NPs	PTT/chemotherapy/CDT	1064 nm, 1.35 W·cm⁻², 10 min	MHCC97H tumor	[58]
Cu(II)/LRu/PDA NPs	PTT/PDT/MRI/photoacoustic tomography	808 nm, 1.0 W·cm⁻², 12 min for PTT; 660 nm, 1.0 W·cm⁻², 12 min for PDT	HeLa tumor	[59]

Back to article page

ISSN: 2055-7124

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com